Firazyr and Effexor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Firazyr (icatibant acetate) and Effexor (venlafaxine hydrochloride). Common drug interactions include hereditary angioedema among females and hereditary angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Firazyr and Effexor. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Firazyr?

Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 5,650 Firazyr users. Check the latest studies of Firazyr.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

On Jul, 27, 2026

18 people who take Firazyr and Effexor together, and have interactions are studied.

What are the common drug interactions of Firazyr and Effexor, by gender? *:

female:

Hereditary angioedema (recurrent episodes of severe swelling)
Drug ineffective
Device related infection
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Renal embolism (an obstruction in a kidney)
Renal impairment (severely reduced kidney function)
Deafness
Exfoliative rash (scaly red generalized skin rash)
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)

male:

Hereditary angioedema (recurrent episodes of severe swelling)
Chest pain
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
Pulmonary embolism (blockage of the main artery of the lung)
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)
Staphylococcal infection (an infection with staphylococcus bacteria)
Device related infection
Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)

What are the common drug interactions of Firazyr and Effexor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chest pain
Dyspnoea (difficult or laboured respiration)
Heart rate increased
Hereditary angioedema (recurrent episodes of severe swelling)
Pulmonary embolism (blockage of the main artery of the lung)

30-39:

Device related infection
Hereditary angioedema (recurrent episodes of severe swelling)
Sepsis (a severe blood infection that can lead to organ failure and death)
Renal embolism (an obstruction in a kidney)
Renal impairment (severely reduced kidney function)
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
Nephrolithiasis (calculi in the kidneys)
Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)
Therapeutic response unexpected
Transaminases increased

40-49:

n/a

50-59:

Device related infection
Exfoliative rash (scaly red generalized skin rash)
Urinary tract infection
Flushing (the warm, red condition of human skin)
General physical health deterioration (weak health status)
Hereditary angioedema (recurrent episodes of severe swelling)
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
Rash erythematous (redness of the skin)
Renal impairment (severely reduced kidney function)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

n/a

What are the existing conditions these people have? *

Hereditary Angioedema (recurrent episodes of severe swelling): 14 people, 77.78%
Pain: 6 people, 33.33%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 22.22%
Immune System Disorder: 4 people, 22.22%
Essential Hypertension (primary hypertension): 4 people, 22.22%
Dyspnea (difficult or laboured breathing): 4 people, 22.22%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 5.56%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Firazyr and Effexor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously